Verastem (VSTM) Operating Income (2011 - 2026)
Verastem (VSTM) recorded quarterly Operating Income of -$44.9 million in Q1 2026, down 153.03% quarter-over-quarter from $84.7 million in Q4 2025, and down 1.64% on a YoY basis from -$45.6 million in Q1 2025.
Verastem (VSTM) Operating Income (2011 - 2026) Analysis & Trends
Verastem's Operating Income history runs 16 years deep, the most recent figure standing at -$44.9 million for Q1 2026.
- In Q1 2026, Operating Income fell 1.64% year-over-year to -$44.9 million; the TTM figure through Mar 2026 stood at -$44.7 million (up 65.89% YoY), while the FY2025 annual figure was -$44.0 million, up 61.73% from the prior year.
- Operating Income was -$44.9 million for Q1 2026 at Verastem, down from $84.7 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $84.7 million in Q4 2025 to a low of -$44.9 million in Q1 2026.
- Historically, Operating Income has averaged -$21.7 million across 5 years, with a median of -$21.4 million in 2022.
- Biggest YoY gain for Operating Income was 368.01% in 2025; the steepest drop was 139.45% in 2025.
- A 5-year view of Operating Income shows it stood at -$16.8 million in 2022, then tumbled by 84.85% to -$31.1 million in 2023, then decreased by 1.45% to -$31.6 million in 2024, then soared by 368.01% to $84.7 million in 2025, then plunged by 153.03% to -$44.9 million in 2026.
- The last three Operating Income figures came in at -$44.9 million (Q1 2026), $84.7 million (Q4 2025), and -$40.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -44.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.90 Mn |
| Dec 31, 2025 | 84.67 Mn |
| Sep 30, 2025 | -40.72 Mn |
| Jun 30, 2025 | -43.76 Mn |
| Mar 31, 2025 | -44.17 Mn |
| Dec 31, 2024 | -31.59 Mn |
| Sep 30, 2024 | -37.03 Mn |
| Jun 30, 2024 | -18.28 Mn |
| Mar 31, 2024 | -28.06 Mn |
| Dec 31, 2023 | -31.14 Mn |
| Sep 30, 2023 | -21.31 Mn |
| Jun 30, 2023 | -20.29 Mn |
| Mar 31, 2023 | -19.34 Mn |
| Dec 31, 2022 | -16.85 Mn |
| Sep 30, 2022 | -17.71 Mn |
| Jun 30, 2022 | -21.40 Mn |
| Mar 31, 2022 | -16.98 Mn |
| Dec 31, 2021 | -16.51 Mn |
| Sep 30, 2021 | -14.85 Mn |
| Jun 30, 2021 | -15.94 Mn |